The Prognostic Value of Early Detection of Minimal Residual Disease as Defined by Flow Cytometry and Gene Mutation Clearance for Myelodysplastic Syndrome Patients After Myeloablative Allogeneic Hematopoietic Stem-Cell Transplantation

High relapse incidence remains a major problem for myelodysplastic syndrome (MDS) patients who have received an allogeneic hematopoietic stem-cell transplantation (allo-HSCT). We retrospectively analyzed the correlations between clinical outcomes and minimal residual disease (MRD) by using mutations...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Chang, Zhou, Lili, Yang, Menglu, Jiang, Shuhui, Shen, Hongjie, Zhu, Mingqing, Chen, Jia, Miao, Miao, Xu, Yang, Wu, Depei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374104/
https://www.ncbi.nlm.nih.gov/pubmed/34422653
http://dx.doi.org/10.3389/fonc.2021.700234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374104/
https://www.ncbi.nlm.nih.gov/pubmed/34422653
http://dx.doi.org/10.3389/fonc.2021.700234

Ejemplares similares